About Transforming growth factor beta-2 proprotein
Transforming growth factor beta-2 proprotein (TGFB2) is a protein
from Homo sapiens identified by UniProt accession
P61812, 414 residues long.
MolForge cross-references it against 0 known binders and
1,056 disease associations.
Target properties
| Protein name | Transforming growth factor beta-2 proprotein |
| UniProt accession | P61812 |
| Gene | TGFB2 |
| Organism | Homo sapiens |
| Length | 414 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (1056)
Diseases linked to this target (Open Targets).
- Loeys-Dietz syndrome · score 0.76
- familial thoracic aortic aneurysm and aortic dissection · score 0.70
- FEV/FVC ratio · score 0.56
- Rare disease with thoracic aortic aneurysm and aortic dissection · score 0.56
- myelodysplastic syndrome · score 0.55
- body height · score 0.50
- BMI-adjusted waist circumference · score 0.49
- vital capacity · score 0.49
- forced expiratory volume · score 0.48
- lean body mass · score 0.48
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P61812-F1 | alphafold | PREDICTED | 80.10 | — |
Amino-acid sequence (414 residues)
MHYCVLSAFL ILHLVTVALS LSTCSTLDMD QFMRKRIEAI RGQILSKLKL TSPPEDYPEP EEVPPEVISI YNSTRDLLQE KASRRAAACE RERSDEEYYA KEVYKIDMPP FFPSENAIPP TFYRPYFRIV RFDVSAMEKN ASNLVKAEFR VFRLQNPKAR VPEQRIELYQ ILKSKDLTSP TQRYIDSKVV KTRAEGEWLS FDVTDAVHEW LHHKDRNLGF KISLHCPCCT FVPSNNYIIP NKSEELEARF AGIDGTSTYT SGDQKTIKST RKKNSGKTPH LLLMLLPSYR LESQQTNRRK KRALDAAYCF RNVQDNCCLR PLYIDFKRDL GWKWIHEPKG YNANFCAGAC PYLWSSDTQH SRVLSLYNTI NPEASASPCC VSQDLEPLTI LYYIGKTPKI EQLSNMIVKS CKCS
Explore Transforming growth factor beta-2 proprotein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets